Breast CancerProstate CancerBladder CancerLung CancerBrain CancerPancreatic CancerOvarian CancerFallopian Tube CancerPeritoneal CancerCancer of LiverCancer of ColonCancer of Head and NeckCancer of StomachCancer of Gastrointestinal TractCancer of RectumCancer of EsophagusCancer of SkinCancer of CervixCancer of KidneyCancer of LarynxCancer of EndometriumCancer of the Bile DuctCancer of VulvaCancer of Bone and Connective TissueLeukemiaLymphomaSpinal Cord Cancer
Investigational drug(s) / intervention(s)
Observation
Observation: No Intervention
Study summary
Observational study that will be collecting clinical and molecular health information from cancer patients who have received comprehensive genomic profiling and meet the specific eligibility criteria outlined for each cohort with the goal of conducting research to advance cancer care and create a dataset that furthers cancer research.
Eligibility
Sex
ALL
Min age
—
Max age
—
Healthy volunteers
No
Inclusion Criteria:
1. Solid or hematologic malignancy.
2. Willing and able to provide informed consent where required.
3. Has received or will receive genomic profiling.
Exclusion Criteria:
1. Individuals without the capacity to consent.
2. Prisoners at the time of enrollment.
Primary outcome measure(s)
Create robust data set of health information — Up to 10 years To create a robust data set of health information about cancer patients who receive comprehensive genomic profiling in order to facilitate future novel precision medicine research
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.